(Q48785723)

15 February 2018

title

Commentary: DLB and PDD: the same or different? Is there a debate? (English)

1 reference

15 February 2018

0 references

Ian McKeith

1

1 reference

15 February 2018

publication date

28 January 2009

1 reference

15 February 2018

International Psychogeriatrics

published in

1 reference

15 February 2018

volume

21

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

220-224

1 reference

15 February 2018

Familial occurrence of dementia and parkinsonism: a systematic review

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

The relationship of Parkinson disease with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

MCI is a clinically useful concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Functional imaging in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

The neuromythology of Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Introduction: for debate: should neuroimaging be a routine investigation in all cases of suspected dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Regulation of attention and response to therapy in dementia by butyrylcholinesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

Dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

7 January 2021

Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

7 January 2021

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

7 January 2021

Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008624

7 January 2021

10.1017/S1041610208008624

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018